Enhancement of Epigastric Skin Flap Survival by Adenovirus-Mediated VEGF Gene Therapy
Authors:
- Przemyslaw LubiatowskiPLPrzemyslaw Lubiatowski
- Corey K. GoldmanCGCorey K. Goldman
- Raffi GurunluogluRGRaffi Gurunluoglu
- Kevin CarnevaleKCKevin Carnevale
- Maria SiemionowMSMaria Siemionow
- 1 May 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 109 (6) , 1986-1993
Abstract
A novel approach to treat ischemic tissues by using gene therapy has recently been introduced on the basis of the angiogenic potential of certain growth factors. The authors investigated the effect of adenovirus-mediated gene therapy with vascular endothelial growth factor (VEGF) delivered into the subdermal space to treat compromised skin flaps. For this purpose, the epigastric skin flap model in rats, based solely on the right inferior epigastric vessels, was used. Thirty male Sprague-Dawley rats were divided into five groups of six rats each. Viral transfection with 108 plaque-forming units was performed 2 days before the epigastric flap elevation. Rats received subdermal injections of adenovirus encoding VEGF (Ad-VEGF) or green fluorescent protein (Ad-GFP) as treatment control. Another set of animals (n = 6) received no injections and were designated as control. To determine whether site of injection had an impact on flap viability, injections were given into the predicted local ischemic area (Ad-VEGF local, n = 6; Ad-GFP local, n = 6) and into the midline of the flap (Ad-VEGF midline, n = 6; Ad-GFP midline, n = 6). A flap measuring 8 × 8 cm was outlined on the abdominal skin extending from the xiphoid process proximally and the pubic region distally, to the anterior axillary lines bilaterally. Then, the epigastric flap was elevated as an island on the right inferior epigastric vessels and sutured back to its bed. Flap viability was evaluated at 7 and 14 days after the first operation. The epigastric flaps were scanned to the computer and areas of hypoxic and/or necrotic zones relative to total flap surface area were measured and expressed as percentages by using Image Pro Plus software. Specimens were taken for histologic evaluation at day 14 before the animals were killed. Combined area of necrotic and hypoxic zones as well as necrotic zone were decreased to 9.7 ± 1.4 percent and 1.4 ± 0.9 percent in Ad-VEGF local, and 11.8 ± 1.9 percent and 3.5 ± 1.64 percent in Ad-VEGF midline compared with the control and Ad-GFP treatment groups (control, 23 ± 3.6 percent and 20.1 ± 3.3 percent; Ad-GFP local, 24.8 ± 4.8 percent and 16.2 ±5.9 percent; and Ad-GFP midline, 23.4 ± 6.9 percent and 19.5 ± 7.7 percent; p <0.05). Histologic evaluation by light microscopy failed to demonstrate any quantitative difference in vascularity of skin flaps between the treatment groups. In this study, the authors demonstrated that adenovirus-mediated gene therapy using VEGF enhanced epigastric skin flap survival, as confirmed by the significant reduction in combined area of necrotic and hypoxic zones of the flap. Compared with the control, both local and midline subdermal injections of Ad-VEGF showed improvement in overall flap survival by 57.9 and 48.7 percent, respectively. The results of this study raise the possibility of using adenovirus-mediated therapeutic angiogenesis for safer flap surgery in high-risk patients. (Plast. Reconstr. Surg. 109: 1986,2002.)Keywords
This publication has 35 references indexed in Scilit:
- Mechanisms of angiogenesis and arteriogenesisNature Medicine, 2000
- Effects of VEGF Administration Following Ischemia on Survival of the Gracilis Muscle Flap in the RatAnnals of Plastic Surgery, 1999
- Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemiaJournal of Vascular Surgery, 1998
- Effect of Vascular Endothelial Growth Factor (VEGF) on Survival of Random Extension of Axial Pattern Skin Flaps in the RatAnnals of Plastic Surgery, 1996
- Hyperbaric Oxygen Therapy in the Management of Crush InjuriesThe Journal of Trauma: Injury, Infection, and Critical Care, 1996
- Basic Fibroblast Growth Factor Has a Beneficial Effect on the Viability of Random Skin Flaps in RatsAnnals of Plastic Surgery, 1994
- The Influence of Intensive Hyperbaric Oxygen Therapy on Skin Flap Survival in a Swine ModelJAMA Otolaryngology–Head & Neck Surgery, 1992
- The Effect of Bovine Basic Fibroblast Growth Factor on Skin Flap Survival in RatsAnnals of Plastic Surgery, 1992
- The effect of basic fibroblast growth factor on the neovascularisation process: skin flap survival and staged flap transfersBritish Journal of Plastic Surgery, 1991
- Utilizing angiogenic agents to expedite the neovascularization process in skin flapsThe Laryngoscope, 1988